DAPT duration after DES: what is the "mandatory" duration?

Affiliations

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Roxana.Mehran@mountsinai.org.
² The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Free article

Editorial

Roxana Mehran et al. J Am Coll Cardiol. 2015.

Free article

. 2015 Mar 24;65(11):1103-6.

doi: 10.1016/j.jacc.2015.01.024.

¹ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: Roxana.Mehran@mountsinai.org.
² The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: bleeding; major adverse cardiac event(s); stent thrombosis.

Comment on

Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.
Palmerini T, Sangiorgi D, Valgimigli M, Biondi-Zoccai G, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Mariani A, Della Riva D, Genereux P, Leon MB, Bhatt DL, Bendetto U, Rapezzi C, Stone GW. Palmerini T, et al. J Am Coll Cardiol. 2015 Mar 24;65(11):1092-102. doi: 10.1016/j.jacc.2014.12.046. J Am Coll Cardiol. 2015. PMID: 25790880 Review.